Natixis Advisors, L.P. Gsk PLC Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $2.16 Million - $2.45 Million	51,304 Added 16.73%	357,988 $15.9 Million
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $2.78 Million - $3.3 Million	69,105 Added 29.09%	306,684 $13.4 Million
Q4 2021 Feb 08, 2022	SELL	$38.88 - $45.31 $1.8 Million - $2.09 Million	-46,202 Reduced 16.28%	237,579 $10.5 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $296,821 - $330,260	7,652 Added 2.77%	283,781 $10.8 Million
Q2 2021 Aug 12, 2021	BUY	$36.52 - $41.46 $209,734 - $238,104	5,743 Added 2.12%	276,129 $11 Million
Q1 2021 May 05, 2021	SELL	$34.27 - $40.01 $2.08 Million - $2.43 Million	-60,685 Reduced 18.33%	270,386 $9.65 Million
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $4.88 Million - $5.72 Million	-143,301 Reduced 30.21%	331,071 $12.2 Million
Q3 2020 Nov 12, 2020	SELL	$38.11 - $42.99 $862,581 - $973,035	-22,634 Reduced 4.55%	474,372 $17.9 Million
Q2 2020 Aug 11, 2020	SELL	$37.87 - $43.58 $5.44 Million - $6.26 Million	-143,735 Reduced 22.43%	497,006 $20.3 Million
Q1 2020 Apr 27, 2020	BUY	$32.47 - $48.83 $405,680 - $610,082	12,494 Added 1.99%	640,741 $24.3 Million
Q4 2019 Feb 10, 2020	BUY	$42.0 - $48.25 $909,804 - $1.05 Million	21,662 Added 3.57%	628,247 $29.5 Million
Q3 2019 Nov 12, 2019	BUY	$40.46 - $43.52 $1.07 Million - $1.15 Million	26,505 Added 4.57%	606,585 $25.9 Million
Q2 2019 Aug 12, 2019	BUY	$39.4 - $42.7 $635,128 - $688,324	16,120 Added 2.86%	580,080 $23.2 Million
Q1 2019 May 15, 2019	BUY	$38.57 - $42.69 $1.68 Million - $1.86 Million	43,519 Added 8.36%	563,960 $23.6 Million
Q4 2018 Feb 13, 2019	SELL	$37.8 - $42.69 $969,305 - $1.09 Million	-25,643 Reduced 4.7%	520,441 $19.9 Million
Q3 2018 Nov 13, 2018	BUY	$39.75 - $42.69 $820,479 - $881,164	20,641 Added 3.93%	546,084 $21.9 Million
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $990,566 - $1.07 Million	25,008 Added 5.0%	525,443 $0
Q1 2018 May 10, 2018	BUY	$36.18 - $40.15 $3.91 Million - $4.34 Million	108,056 Added 27.54%	500,435 $19.6 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $3.43 Million - $4.06 Million	-96,945 Reduced 19.81%	392,379 $13.9 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $19.3 Million - $20.3 Million	489,324	489,324 $19.9 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account